Neogen adds Jeff Capello and Aashima Gupta to its Board of Directors

– USA, MI –  Neogen Corporation (NASDAQ: NEOG), a food and animal safety leader, announced the appointments of Jeff Capello and Aashima Gupta to its Board of Directors today.

“We are pleased to add these two experienced industry professionals to Neogen’s Board of Directors. Their involvement in the global healthcare and biotechnology industries will be a significant benefit to Neogen as the company moves into this new era, and we are confident their expertise will be valuable as Neogen continues to grow,” said Board Chair, Jim Borel.

About Jeffrey Capello

Jeff Capello is a senior finance executive with over 30 years of experience helping companies create significant value for their shareholders. He served as CFO for publicly held and private equity-backed companies, including PerkinElmer, Boston Scientific, Ortho Clinical Diagnostic, Beacon Health Options, and Biogen. Jeff also served on the Board of Directors for several early-stage publicly held biotechnology companies as Audit Committee Chair, including Sirtris, OvaScience, and Flex Pharma. He is the Managing Member at Monomoy Advisors, a financial advisory firm that counsels senior leadership on shareholder value creation strategies.

About Aashima Gupta

Aashima Gupta is a strategic global leader with over 25 years of experience working at the intersection of health and technology, with extensive experience in complex large-scale enterprise environments. She worked in technology development across several organizations, including NIIT, Fidelity Investments, J.P. Morgan Chase, Apigee, and Kaiser Permanente. She joined Google in 2017 and serves as the Global Director for Healthcare Provider Solutions at Google Cloud. In this role, she sets the direction for transformative healthcare solutions and leads engagement with key healthcare executives in growing, differentiating, and enhancing businesses through technology transformation, ranging from new models for care, revenue generation, and improved patient experiences. Aashima serves on the Board of Directors for, IntelyCare, and the Board of Advisors for HIMSS NA. In 2019, she was recognized as the Most Influential Women in Healthcare by HIMSS and received the Top 100 FEMTech Award and Champion of Health Award.

About Neogen

Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating to “Every day, protect the people and animals we care about.” The company’s Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen’s Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.